NHG advised the Corporación Andina de Fomento (CAF) on the equity investment of Patia Biopharma, for the development of a cost-efficient genetic test to identify high-risk patients of diabetes that may get SARS-Cov-2 in order to adopt precautionary measures, through the run of tests and samples compilations in Spain, Mexico and Peru.
“Nader, Hayaux & Goebel lead sale of a minority stake in Grupo de Diagnostico Aries to Caisse de dépôt et placement du Québec (CDPQ”
Grupo de Diagnostico Aries entered into a definitive agreement to sell a 20.25% stake to Caisse de dépôt et placement du Québec, as a result of a process organized and structured by BBVA with the advice of Nader, Hayaux & Goebel.
It was considered as one of the most attractive private equity deals of 2021, that attracted the interest of many private equity funds. This a new transaction by NHG in the health industry where it is a market leader.
NHG acted as Mexican legal counsel to Upper90 Capital Management, LP on a Senior Secured Term Loan for USD $50 million, secured by a first priority lien on all assets and shares of Valoreo, Inc and subsidiaries, including equity interest in and assets of Valoreo Mexican subsidiaries.